Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells.

ABSTRACT:

Unlabelled

There exists a worldwide shortage of donor livers available for orthotropic liver transplantation and hepatocyte transplantation therapies. In addition to their therapeutic potential, primary human hepatocytes facilitate the study of molecular and genetic aspects of human hepatic disease and development and provide a platform for drug toxicity screens and identification of novel pharmaceuticals with potential to treat a wide array of metabolic diseases. The demand for human hepatocytes, therefore, heavily outweighs their availability. As an alternative to using donor livers as a source of primary hepatocytes, we explored the possibility of generating patient-specific human hepatocytes from induced pluripotent stem (iPS) cells.

Conclusion

We demonstrate that mouse

SUBMITTER: Si-Tayeb K 

PROVIDER: S-EPMC2946078 | biostudies-literature | 2010 Jan

REPOSITORIES: biostudies-literature